alpha-cyano-4-hydroxycinnamate has been researched along with Clinically Isolated CNS Demyelinating Syndrome in 1 studies
alpha-cyano-4-hydroxycinnamate: specific inhibitor of pyruvate transport in rat liver mitochondria & human erythrocytes; structure
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, S | 1 |
| Ren, C | 1 |
| Qu, X | 1 |
| Wu, X | 1 |
| Dong, F | 1 |
| Chand, YK | 1 |
| Fan, H | 1 |
| Yao, R | 1 |
| Geng, D | 1 |
1 other study available for alpha-cyano-4-hydroxycinnamate and Clinically Isolated CNS Demyelinating Syndrome
| Article | Year |
|---|---|
miR-219 attenuates demyelination in cuprizone-induced demyelinated mice by regulating monocarboxylate transporter 1.
Topics: Animals; Cell Differentiation; Cell Proliferation; Cells, Cultured; Corpus Callosum; Coumaric Acids; | 2017 |